INVIVO COMPARISON OF 16-ALPHA-[BR-77]BROMOESTRADIOL-17-BETA AND 16-ALPHA-[I-125]IODOESTRADIOL-17-BETA
- 1 January 1982
- journal article
- research article
- Vol. 23 (5) , 420-424
Abstract
Estrogen-receptor-binding radiopharmaceuticals of high specific activity, 16.alpha.-[77Br]bromoestradiol-17.beta. and 16.alpha.[125I]iodoestradiol-17.beta., were compared in immature female rats. The iodoestradiol has slightly higher uterine uptake at 1 h after injection, whereas the brominated analog has significanlty enhanced uptake at later times. The similar behavior of the 2 compounds in vivo suggests that estradiol labeled with 123I, 77Br on 75Br could be used interchangeably for the imaging of breast tumors containing estrogen receptors. Coinjection of 16.alpha.-[125I]iodoestradiol as an internal standard may be useful for comparison of different radiohalogenated estrogens.This publication has 3 references indexed in Scilit:
- 16-ALPHA-(BR-77)BROMOESTRADIOL-17-BETA - A HIGH SPECIFIC-ACTIVITY, GAMMA-EMITTING TRACER WITH UPTAKE IN RAT UTERUS AND INDUCED MAMMARY-TUMORS1981
- RECEPTOR-BINDING RADIOPHARMACEUTICALS FOR IMAGING BREAST-TUMORS - ESTROGEN-RECEPTOR INTERACTIONS AND SELECTIVITY OF TISSUE UPTAKE OF HALOGENATED ESTROGEN ANALOGS1980
- Interaction of 16 alpha-[125I]iodo-estradiol with estrogen receptor and other steroid-binding proteins.Proceedings of the National Academy of Sciences, 1980